123 related articles for article (PubMed ID: 38777246)
1. Exhaled breath analysis in adult patients with cystic fibrosis by real-time proton mass spectrometry.
Mustafina M; Silantyev A; Krasovskiy S; Chernyak A; Naumenko Z; Suvorov A; Gognieva D; Abdullaev M; Bektimirova A; Bykova A; Dergacheva V; Betelin V; Kopylov P
Clin Chim Acta; 2024 Jun; 560():119733. PubMed ID: 38777246
[TBL] [Abstract][Full Text] [Related]
2. Online exhaled gas measurements for radiotherapy patients by proton transfer reaction mass spectrometry.
Zou X; Zhou W; Shen C; Wang H; Lu Y; Wang H; Chu Y
J Environ Radioact; 2016 Aug; 160():135-40. PubMed ID: 27209162
[TBL] [Abstract][Full Text] [Related]
3. Cross Platform Analysis of Volatile Organic Compounds Using Selected Ion Flow Tube and Proton-Transfer-Reaction Mass Spectrometry.
Lin GP; Vadhwana B; Belluomo I; Boshier PR; Španěl P; Hanna GB
J Am Soc Mass Spectrom; 2021 May; 32(5):1215-1223. PubMed ID: 33831301
[TBL] [Abstract][Full Text] [Related]
4. Exhaled gases online measurements for esophageal cancer patients and healthy people by proton transfer reaction mass spectrometry.
Zou X; Zhou W; Lu Y; Shen C; Hu Z; Wang H; Jiang H; Chu Y
J Gastroenterol Hepatol; 2016 Nov; 31(11):1837-1843. PubMed ID: 26996099
[TBL] [Abstract][Full Text] [Related]
5. Exhaled breath profiling using broadband quantum cascade laser-based spectroscopy in healthy children and children with asthma and cystic fibrosis.
van Mastrigt E; Reyes-Reyes A; Brand K; Bhattacharya N; Urbach HP; Stubbs AP; de Jongste JC; Pijnenburg MW
J Breath Res; 2016 Apr; 10(2):026003. PubMed ID: 27058305
[TBL] [Abstract][Full Text] [Related]
6. Proton transfer reaction time-of-flight mass spectrometric measurements of volatile compounds contained in peppermint oil capsules of relevance to real-time pharmacokinetic breath studies.
Malásková M; Henderson B; Chellayah PD; Ruzsanyi V; Mochalski P; Cristescu SM; Mayhew CA
J Breath Res; 2019 Jul; 13(4):046009. PubMed ID: 31163413
[TBL] [Abstract][Full Text] [Related]
7. Chemical Analysis of Exhaled Vape Emissions: Unraveling the Complexities of Humectant Fragmentation in a Human Trial Study.
Hopstock KS; Perraud V; Dalton AB; Barletta B; Meinardi S; Weltman RM; Mirkhanian MA; Rakosi KJ; Blake DR; Edwards RD; Nizkorodov SA
Chem Res Toxicol; 2024 Jun; 37(6):1000-1010. PubMed ID: 38769630
[TBL] [Abstract][Full Text] [Related]
8. Real-time exhaled breath analysis in patients with cystic fibrosis and controls.
Gaisl T; Bregy L; Stebler N; Gaugg MT; Bruderer T; García-Gómez D; Moeller A; Singer F; Schwarz EI; Benden C; M-L Sinues P; Zenobi R; Kohler M
J Breath Res; 2018 Apr; 12(3):036013. PubMed ID: 29555894
[TBL] [Abstract][Full Text] [Related]
9. Preliminary method for profiling volatile organic compounds in breath that correlate with pulmonary function and other clinical traits of subjects diagnosed with cystic fibrosis: a pilot study.
Woollam M; Siegel AP; Grocki P; Saunders JL; Sanders DB; Agarwal M; Davis MD
J Breath Res; 2022 Feb; 16(2):. PubMed ID: 35120338
[TBL] [Abstract][Full Text] [Related]
10. Extending PTR based breath analysis to real-time monitoring of reactive volatile organic compounds.
Pugliese G; Trefz P; Brock B; Schubert JK; Miekisch W
Analyst; 2019 Dec; 144(24):7359-7367. PubMed ID: 31663533
[TBL] [Abstract][Full Text] [Related]
11. Standardised exhaled breath collection for the measurement of exhaled volatile organic compounds by proton transfer reaction mass spectrometry.
Bikov A; Paschalaki K; Logan-Sinclair R; Horváth I; Kharitonov SA; Barnes PJ; Usmani OS; Paredi P
BMC Pulm Med; 2013 Jul; 13():43. PubMed ID: 23837867
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Ambient and Atmospheric Pressure Ion Sources for Cystic Fibrosis Exhaled Breath Condensate Ion Mobility-Mass Spectrometry Metabolomics.
Zang X; Pérez JJ; Jones CM; Monge ME; McCarty NA; Stecenko AA; Fernández FM
J Am Soc Mass Spectrom; 2017 Aug; 28(8):1489-1496. PubMed ID: 28364225
[TBL] [Abstract][Full Text] [Related]
13. Effects of humidity, CO
Trefz P; Schubert JK; Miekisch W
J Breath Res; 2018 Mar; 12(2):026016. PubMed ID: 29199640
[TBL] [Abstract][Full Text] [Related]
14. Assessing the feasibility and acceptability of online measurements of exhaled volatile organic compounds (VOCs) in children with preschool wheeze: a pilot study.
Holden K; Makinde M; Wilde M; Richardson M; Coats T; Monks P; Gaillard EA
BMJ Paediatr Open; 2021; 5(1):e001003. PubMed ID: 34568587
[TBL] [Abstract][Full Text] [Related]
15. Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients.
Kos R; Brinkman P; Neerincx AH; Paff T; Gerritsen MG; Lammers A; Kraneveld AD; Heijerman HGM; Janssens HM; Davies JC; Majoor CJ; Weersink EJ; Sterk PJ; Haarman EG; Bos LD; Maitland-van der Zee AH;
J Cyst Fibros; 2022 Jan; 21(1):e28-e34. PubMed ID: 34016557
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive detection of lung cancer by analysis of exhaled breath.
Bajtarevic A; Ager C; Pienz M; Klieber M; Schwarz K; Ligor M; Ligor T; Filipiak W; Denz H; Fiegl M; Hilbe W; Weiss W; Lukas P; Jamnig H; Hackl M; Haidenberger A; Buszewski B; Miekisch W; Schubert J; Amann A
BMC Cancer; 2009 Sep; 9():348. PubMed ID: 19788722
[TBL] [Abstract][Full Text] [Related]
17. Metabolomics of volatile organic compounds in cystic fibrosis patients and controls.
Robroeks CM; van Berkel JJ; Dallinga JW; Jöbsis Q; Zimmermann LJ; Hendriks HJ; Wouters MF; van der Grinten CP; van de Kant KD; van Schooten FJ; Dompeling E
Pediatr Res; 2010 Jul; 68(1):75-80. PubMed ID: 20351658
[TBL] [Abstract][Full Text] [Related]
18. Screening for emphysema via exhaled volatile organic compounds.
Cristescu SM; Gietema HA; Blanchet L; Kruitwagen CL; Munnik P; van Klaveren RJ; Lammers JW; Buydens L; Harren FJ; Zanen P
J Breath Res; 2011 Dec; 5(4):046009. PubMed ID: 22071870
[TBL] [Abstract][Full Text] [Related]
19. Effects of modular ion-funnel technology onto analysis of breath VOCs by means of real-time mass spectrometry.
Pugliese G; Piel F; Trefz P; Sulzer P; Schubert JK; Miekisch W
Anal Bioanal Chem; 2020 Oct; 412(26):7131-7140. PubMed ID: 32794005
[TBL] [Abstract][Full Text] [Related]
20. Elimination characteristics of post-operative isoflurane levels in alveolar exhaled breath via PTR-MS analysis.
Fernández Del Río R; O'Hara ME; Pemberton P; Whitehouse T; Mayhew CA
J Breath Res; 2016 Oct; 10(4):046006. PubMed ID: 27732571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
